{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T19:24:48Z","timestamp":1783797888071,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10528-023-10480-z","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T15:01:43Z","timestamp":1692198103000},"page":"1263-1276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Assessment of Ecotropic Viral Integration Site 2B (EVI2B) Gene in Juvenile Myelomonocytic Leukemia and Neurofibromatosis Type 1 NF1 Tumors"],"prefix":"10.1007","volume":"62","author":[{"given":"Parisa","family":"Saharafi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130rem","family":"Akar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel","family":"Ersoy-Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Anlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Varan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Vargel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mualla","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukriye","family":"Ayter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"key":"10480_CR1","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.5604\/17322693.1185213","volume":"69","author":"A Abramowicz","year":"2015","unstructured":"Abramowicz A, Gos M (2015) Neurofibromin\u2014protein structure and cellular functions in the context of neurofibromatosis type I pathogenesis. Postepy Hig Med Dosw (online) 69:1331\u20131348","journal-title":"Postepy Hig Med Dosw (online)"},{"key":"10480_CR2","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000369802","volume":"83","author":"C Bizzarri","year":"2015","unstructured":"Bizzarri C, Bottaro G (2015) Endocrine implications of neurofibromatosis 1 in childhood. Horm Res Paediatr 83:232\u2013241","journal-title":"Horm Res Paediatr"},{"key":"10480_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0888-7543(90)90199-5","volume":"7","author":"RM Cawthon","year":"1990","unstructured":"Cawthon RM, O\u2019Connell P, Buchberg AM, Viskochil D, Weiss RB, Culver M, Stevens J, Jenkins NA, Copeland NG, White R (1990) Identification and characterization of transcripts from the neurofibromatosis 1 region: the sequence and genomic structure of EVI2 and mapping of other transcripts. Genomics 7:555\u2013565","journal-title":"Genomics"},{"key":"10480_CR4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/0888-7543(91)90410-G","volume":"9","author":"RM Cawthon","year":"1991","unstructured":"Cawthon RM, Andersen LB, Buchberg AM, Xu GF, O\u2019Connell P, Viskochil D, Weiss RB, Wallace MR, Marchuk DA, Culver M et al (1991) cDNA sequence and genomic structure of EV12B, a gene lying within an intron of the neurofibromatosis type 1 gene. Genomics 9:446\u2013460","journal-title":"Genomics"},{"key":"10480_CR5","doi-asserted-by":"publisher","first-page":"7138","DOI":"10.1128\/jvi.69.11.7138-7146.1995","volume":"69","author":"BC Cho","year":"1995","unstructured":"Cho BC, Shaughnessy JD Jr, Largaespada DA, Bedigian HG, Buchberg AM, Jenkins NA, Copeland NG (1995) Frequent disruption of the Nf1 gene by a novel murine AIDS virus-related provirus in BXH-2 murine myeloid lymphomas. J Virol 69:7138\u20137146","journal-title":"J Virol"},{"key":"10480_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1089\/104454999315240","volume":"18","author":"D Kaufmann","year":"1999","unstructured":"Kaufmann D, Gruener S, Braun F, Stark M, Griesser J, Hoffmeyer S, Bartelt B (1999) EVI2B, a gene lying in an intron of the neurofibromatosis type 1 (NF1) gene, is as the NF1 gene involved in differentiation of melanocytes and keratinocytes and is overexpressed in cells derived from NF1 neurofibromas. DNA Cell Biol 18:345\u2013356","journal-title":"DNA Cell Biol"},{"key":"10480_CR7","doi-asserted-by":"publisher","first-page":"5095","DOI":"10.1128\/jvi.69.8.5095-5102.1995","volume":"69","author":"DA Largaespada","year":"1995","unstructured":"Largaespada DA, Shaughnessy JD Jr, Jenkins NA, Copeland NG (1995) Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels. J Virol 69:5095\u20135102","journal-title":"J Virol"},{"key":"10480_CR8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3324\/haematol.2013.093278","volume":"99","author":"A Liss","year":"2014","unstructured":"Liss A, Ooi CH, Zjablovskaja P, Benoukraf T, Radomska HS, Ju C, Wu M, Balastik M, Delwel R, Brdicka T, Tan P, Tenen DG, Alberich-Jorda M (2014) The gene signature in CCAAT-enhancer-binding protein alpha dysfunctional acute myeloid leukemia predicts responsiveness to histone deacetylase inhibitors. Haematologica 99:697\u2013705","journal-title":"Haematologica"},{"key":"10480_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jbior.2014.04.002","volume":"55","author":"O Maertens","year":"2014","unstructured":"Maertens O, Cichowski K (2014) An expanding role for RAS GTPase activating proteins (RAS GAPs) in cancer. Adv Biol Regul 55:1\u201314","journal-title":"Adv Biol Regul"},{"key":"10480_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0002-9440(10)63992-2","volume":"70","author":"D Muir","year":"2001","unstructured":"Muir D, Neubauer D, Lim IT, Yachnis AT, Wallace MR (2001) Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells. Am J Pathol 158(2):501\u2013513. https:\/\/doi.org\/10.1016\/S0002-9440(10)63992-2","journal-title":"Clin Genet"},{"key":"10480_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cancergencyto.2005.08.029","volume":"165","author":"S Oguzkan","year":"2006","unstructured":"Oguzkan S, Terzi YK, Cinbis M, Anlar B, Aysun S, Ayter S (2006) Molecular genetic analyses in neurofibromatosis type 1 patients with tumors. Cancer Genet Cytogenet 165:167\u2013171","journal-title":"Cancer Genet Cytogenet"},{"key":"10480_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2119\/molmed.2010.00079","volume":"17","author":"E Pasmant","year":"2011","unstructured":"Pasmant E, Masliah-Planchon J, Levy P, Laurendeau I, Ortonne N, Parfait B, Valeyrie-Allanore L, Leroy K, Wolkenstein P, Vidaud M, Vidaud D, Bieche I (2011) Identification of genes potentially involved in the increased risk of malignancy in NF1-microdeleted patients. Mol Med 17:79\u201387","journal-title":"Mol Med"},{"key":"10480_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/pde.13064","volume":"34","author":"S Paulus","year":"2017","unstructured":"Paulus S, Koronowska S, Folster-Holst R (2017) Association between juvenile myelomonocytic leukemia, juvenile xanthogranulomas and neurofibromatosis type 1: case report and review of the literature. Pediatr Dermatol 34:114\u2013118","journal-title":"Pediatr Dermatol"},{"key":"10480_CR13","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1038\/onc.2016.464","volume":"36","author":"A Pemov","year":"2017","unstructured":"Pemov A, Li H, Patidar R, Hansen NF, Sindiri S, Hartley SW, Wei JS, Elkahloun A, Chandrasekharappa SC, Program NCS, Boland JF, Bass S, Laboratory NDCGR, Mullikin JC, Khan J, Widemann BC, Wallace MR, Stewart DR (2017) The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas. Oncogene 36:3168\u20133177","journal-title":"Oncogene"},{"key":"10480_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/01677063.2018.1456538","volume":"32","author":"P Sharafi","year":"2018","unstructured":"Sharafi P, Ayter S (2018) Possible modifier genes in the variation of neurofibromatosis type 1 clinical phenotypes. J Neurogenet 32:65\u201377","journal-title":"J Neurogenet"},{"key":"10480_CR15","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00381-011-1648-x","volume":"28","author":"YK Terzi","year":"2012","unstructured":"Terzi YK, Sirin B, Hosgor G, Serdaroglu E, Anlar B, Aysun S, Ayter S (2012) Two pathogenic NF1 gene mutations identified in DNA from a child with mild phenotype. Childs Nerv Syst 28:943\u2013946","journal-title":"Childs Nerv Syst"},{"key":"10480_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0004.2006.00639.x","volume":"70","author":"AB Trovo-Marqui","year":"2006","unstructured":"Trovo-Marqui AB, Tajara EH (2006) Neurofibromin: a general outlook. Clin Genet 70:1\u201313","journal-title":"Clin Genet"},{"key":"10480_CR17","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/cdd.2017.6","volume":"24","author":"P Zjablovskaja","year":"2017","unstructured":"Zjablovskaja P, Kardosova M, Danek P, Angelisova P, Benoukraf T, Wurm AA, Kalina T, Sian S, Balastik M, Delwel R, Brdicka T, Tenen DG, Behre G, Fiore F, Malissen B, Horejsi V, Alberich-Jorda M (2017) EVI2B is a C\/EBPalpha target gene required for granulocytic differentiation and functionality of hematopoietic progenitors. Cell Death Differ 24:705\u2013716","journal-title":"Cell Death Differ"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-023-10480-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-023-10480-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-023-10480-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T08:12:55Z","timestamp":1713514375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-023-10480-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10480"],"URL":"https:\/\/doi.org\/10.1007\/s10528-023-10480-z","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,16]]},"assertion":[{"value":"23 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the Institutional Ethics Committee of Hacettepe University, ANKARA (Report number: GO16\/674\u201307, Date:08.11.2016). Written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"The authors give the publisher the permission to publish the work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}